# Azenta Life Sciences (AZTA) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/AZTA
## Company Profile
- Ticker: AZTA
- Exchange: NASDAQ
- Sector: Life Science Tools
- Location: United States
- Tags: Life Science Tools
## Stock Data
- Close: 33.53 USD
- Market cap: 1079954397.72 USD
- Last updated: 2026-08-12
## Business Overview
### Life-Sciences Sample Management
Azenta provides sample-management and laboratory services that support biological research and drug development. Its capabilities span automated storage, cold-chain logistics, sample repositories and related informatics used by pharmaceutical, biotechnology and academic customers.
### Multiomics Services
The Multiomics business provides genomic and analytical services that help customers characterize biological samples and generate research data. Azenta is restructuring this operation to improve commercial execution, productivity and its operating footprint.
### Focused Portfolio
Azenta is concentrating on businesses connected to sample management and multiomics after treating B Medical Systems as a discontinued operation. This portfolio structure positions the company primarily as an infrastructure and services provider to the life-sciences industry.
## Why The Stock Is Moving

As of Aug 12, 2026, AZTA closed up 0.42% at $33.53. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-04 20:30 EST — [Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.](https://biopharmsignal.com/news/AZTA/azenta-reports-third-quarter-results-for-fiscal-2026-ended-june-30-2026-a074df8d) — Source: Azenta Life Sciences
- 2026-07-22 20:05 EST — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff) — Source: Azenta Life Sciences
- 2026-07-08 12:00 EST — [Azenta Completes Sale of B Medical Systems](https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834) — Source: Azenta Life Sciences
- 2026-05-21 20:05 EST — [Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report](https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report) — Source: Azenta Life Sciences
- 2026-05-05 20:30 EST — [Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029](https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029) — Source: Azenta Life Sciences